Pharmaceutical quality of eight generics of ceftriaxone preparation for injection in Eastern Asia

References

• RichardsD,HeelR, BrogdenR, SpeightT, AveryG.Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.Drugs.1984;27(6):469–527.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency EMA. Referral of the Committee for Medicinal Products for Human Use (CHMP) on Rocephin. 2014. Available from URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Rocephin/human_referral_000362.jsp&mid=WC0b01ac05805c516f (last access 20 February 2014).
   Google Scholar
• World Health Organization WHO. WHO model list of essential medicines, 18th list. 2013. Available from URL: http://www.who.int/medicines/publications/essentialmedicines/en/index.html (last access 28 February 2014).
   Google Scholar
• Food and Drug Administration FDA. Drugs@FDA Glossary of Terms. Available from URL: http://www.fda.gov/Drugs/InformationOnDrugs/ucm079436#TE (last access 20 February 2014).
   Google Scholar
• SnymanJ.Editorial - bioequivalence: should we trust generic antibiotics?South Afr J Epidemiol Infect.2005;20(3) :78–9.
   Google Scholar
• Japanese Pharmaceutical and Food Safety Bureau. Guideline for Bioequivalence Studies of Generic Products, Attachment 1 of Division-Notification 0229 No. 10 [translation in English]. 2012. Available from URL: http://www.nihs.go.jp/drug/be-guide%28e%9/Generic/GL-E_120229_BE.pdf (last access 19 March 2014).
   Google Scholar
• LambertPA, ConwayBR.Pharmaceutical quality of ceftriaxone generic drug products compared with Rocephin®.J Chemother.2003;15(4):357–68.
   PubMed Web of Science ®Google Scholar
• TangeM, YoshidaM, NakaiY, UchidaT.Comparison between original and generic versions of ceftriaxone sodium preparation for injection: compatibility with calcium-containing product.Chem Pharm Bull (Tokyo).2012;60(4):429–34.
   PubMed Web of Science ®Google Scholar
• SchitoGC, KeenanMHJ.Predicting the clinical efficacy of generic formulations of ceftriaxone.J Chemother.2005;17(Suppl 2):33–40.
   PubMedGoogle Scholar
• DonghyunP, KwanhoS. Impact of population aging on Asia’s future growth. Asian Development Bank (ADB) Economics Working Paper Series, ADB, Manila, Philippines. Vol. 281. 2011. p. 1–30.
   Google Scholar
• KapczynskiA.Engineered in India-Patent Law 2.0.N Engl J Med.2013;369(6):497–9.
   PubMed Web of Science ®Google Scholar
• Munsell A. Munsell Book of Colour. New Windsor, New York: GretagMacBeter;1996.
   Google Scholar
• Anonymous. European Pharmacopoeia 7·0. 2011.
   Google Scholar
• European Medicines Agency EMA. Guideline on the specification limits for residues of metal catalysts or metal reagents. Doc Ref EMEA/CHMP/SWP/4446/2000. 2008. Available from URL: www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003586.pdf (last access 20 January 2014).
   Google Scholar
• SmithJC, TaroccoG, MerazziF, SalzmannU.Are generic formulations of carvedilol of inferior pharmaceutical quality compared with the branded formulation?Curr Med Res Opin.2006;22(4):709–20.
   PubMed Web of Science ®Google Scholar
• TaylorPW, KeenanMHJ.Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane.Curr Med Res Opin.2006;22(3):603–15.
   PubMed Web of Science ®Google Scholar
• NightingaleC.A survey of the quality of generic clarithromycin products manufactured in Slovenia and Israel.Adv Ther.2000;17(3):167–78.
   PubMed Web of Science ®Google Scholar
• NightingaleC.A survey of the quality of generic clarithromycin products from 18 countries.Clin Drug Investig.2005;25(2):135–52.
   PubMed Web of Science ®Google Scholar
• VesgaO, AgudeloM, SalazarBE, RodriguezCA, ZuluagaAF.Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator.Antimicrob Agents Chemother.2010;54(8):3271–9.
   PubMed Web of Science ®Google Scholar
• LehrH-A, BrunnerJ, RangoonwalaR, KirkpatrickCJ.Particulate matter contamination of intravenous antibiotics aggravates loss of functional capillary density in postischemic striated muscle.Am J Respir Crit Care Med.2002;165(4):514–20.
   PubMed Web of Science ®Google Scholar
• ZuluagaAF, AgudeloM, CardenoJ, RodriguezCA, VesgaO.Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.PLoS One. 2010;20(5):e10744. Epub 2010/05/28.
   Google Scholar
• MastorakiE, MichalopoulosA, KriarasI, MouchtouriE, FalagasM, KaratzaD, et al.Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime.J Infect.2008;56(1):35–9.
   PubMed Web of Science ®Google Scholar
• RodriguezCA, AgudeloM, CatañoJC, ZuluagaAF, VesgaO.Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia.J Infect.2009;59(4):277–80.
   PubMed Web of Science ®Google Scholar
• RodriguezCA, AgudeloM, ZuluagaAF, VesgaO.Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model.Antimicrob Agents Chemother.2012;56(1):243–7.
   PubMed Web of Science ®Google Scholar
• ConciaE, NovelliA, SchitoGC, MarcheseA.Ideal microbiological and pharmacological characteristics of a quality antimicrobial agent: comparing original and generic molecules.J Chemother.2007;19(6):609–19.
   PubMed Web of Science ®Google Scholar
• RichardsG, ElliottE, SchaddockE.A comparison of the pharmacokinetics of aspen ceftriaxone and Rocephin in community-acquired meningitis.South African Med J.2013;103(12):906–9.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration FDA. FDA statement about product quality of parenteral vancomycin products, March 14, 2012. U.S. FDA, Rockville, MD. Available from URL: www.fda.gov/Drugs/DrugSafety/ucm295414.htm (last access 20 February 2014).
   Google Scholar
• KirkpatrickC, RamzanR, MykhayloR, MikeB, ShahramG.Non-equivalence of antibiotic generic drugs and risk for intensive care patients.Pharmaceut Reg Affairs. 2013;2(1).
   Google Scholar
• BaniasadiS, DorudiniaA, MobarhanM, Karimi GamishanM, FahimiF.Microbial contamination of single- and multiple-dose vials after opening in a pulmonary teaching hospital.Braz J Infect Dis.2013;17(1):69–73.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention CDC. Invasive Staphylococcus aureus infections associated with pain injections and reuse of single-dose vials-Arizona and Delaware, 2012.MMWR Morb Mortal Wkly Rep.2012;61(27):501–4.
   PubMedGoogle Scholar
• GrohskopfLA, RothVR, FeikinDR, ArduinoMJ, CarsonLA, TokarsJI, et al.Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center.N Engl J Med.2001;344(20):1491–7.
   PubMed Web of Science ®Google Scholar
• ManchikantiL, FalcoF, BenyaminR, CarawayD, WargoB, et al.Assessment of infection control practices for interventional techniques: a best evidence synthesis of safe injection practices and use of single-dose medication vials.Pain Physician.2012;15(5):E573–614.
   PubMed Web of Science ®Google Scholar